Connect with us

National

Scientists develop new method to estimate prevalence of SARS-CoV-2 antibodies – News-Medical.Net

In the study, which appeared on the pre-print server medRxiv*, the team also modeled the pandemic phases with exponential growth and decay. The model improves upon…

Published

on

Article feature image

The coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to wreak havoc across the globe.
The extent of the pandemic is still unknown since many of the infections were asymptomatic.
Serology testing provides a paradigm for estimating the number of individuals who have been infected with SARS-CoV-2, including cases undetectable by routine testing.
Traditional statistical methods to estimate antibody response do not incorporate…

Click here to view the original article.